Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for OFEV (nintedanib), investigating a potential treatment for children and adolescents between 6 to 17 years old ...
read more
Wednesday, November 18, 2015
Sandoz, a Novartis company, has announced today the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Neulasta® (pegfilgrastim)* - a...
read more
Tuesday, December 29, 2015
Epizyme, Inc., has announced that the U.S. Food and Drug Administration’s (FDA) Division of Hematology Products has accepted the company’s investigational new drug (IND) application for tazemetostat for the treatment of adults with diffuse large B-...
read more
Wednesday, September 02, 2015
Bristol-Myers Squibb announced that the FDA has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo for the treatment of previously treated patients with non-squamous (NSQ) non-small cell lung cancer (NSCLC...
read more
Aralez Pharmaceuticals has announced that the U.S. Food and Drug Administration ("FDA") has acknowledged acceptance of the New Drug Application ("NDA") for its investigational candidate, YOSPRALA™(PA32540/PA8140) for the secondary prevention of ...
read more
Thursday, August 30, 2018
Faubel and ELPRO have announced a new joint temperature monitoring system.
read more
Monday, September 30, 2019
Fate Therapeutics has opened its cGMP compliant manufacturing facility for the clinical production of its off-the-shelf natural killer cell and chimeric antigen receptor (CAR) T-cell product candidates.
read more
Thursday, October 20, 2022
Farmabios, Novasep and PharmaZell officially announced that they are coming together under the new brand Axplora.
read more
Fareva announced the opening of a new GMP Pilot Unit at its Pau site dedicated to the production of liquid and lyophilized injectable forms.
read more
Thursday, December 09, 2021
Fareva and ApiJect Systems, Corp. have announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large ...
read more
Famar has announced the planned acquisition of the Pointe-Claire, Quebec, a manufacturing site from the Consumer Health Division of Bayer.
read more
Wednesday, February 10, 2021
FairJourney Biologics and IONTAS have announced the launch of a new protein sciences division, Flow Eighteen38.
read more
Tuesday, December 01, 2020
FairJourney Biologics and IONTAS have signed an agreement to discover antibodies with Pandion Therapeutics.
read more
Patient-focused pharmaceutical company continues to partner with hospitals and ambulatory surgery centers to meet increased demand for essential compounded sterile medication during, and beyond, COVID-19; 503B outsourcing supports patient safety and ...
read more
Thursday, February 03, 2022
Fagron has reached an agreement to acquire Letco Medical. The acquisition price is $34 million.
read more